![Richard Graydon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Graydon worked as Director-Clinical Development at Daiichi Sankyo, Inc. Dr. Graydon worked as Chief Medical Officer at Atossa Therapeutics, Inc. Dr. Graydon worked as Chief Medical Officer at Immix Biopharma, Inc. Dr. Graydon earned a doctorate from Stanford University and completed undergraduate studies at Cornell University.
| Sociétés | Poste | Fin |
|---|---|---|
| IMMIX BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 17/07/2026 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
| ATOSSA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Immix Biopharma, Inc.
 Immix Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cancer patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
